Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.42 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.37 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.37 |
| ▸ | STAT3 | P40763 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | PSMD10 | O75832 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALB | P02768 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9723718 | 0.88 | PLA2G2C (0.44) | PLA2G2CMCHR1STAT3ALDH1A1CYP3A4 | |
| SCHEMBL9512608 | 0.88 | PLA2G2C (0.44) | PLA2G2CMCHR1STAT3ALDH1A1CYP3A4 | |
| SCHEMBL9488453 | 0.88 | PLA2G2C (0.44) | PLA2G2CMCHR1STAT3ALDH1A1CYP3A4 | |
| SCHEMBL9723827 | 0.86 | PLA2G2C (0.42) | PLA2G2CMCHR1STAT3ALDH1A1CYP3A4 | |
| SCHEMBL6818282 | 0.83 | PLA2G2C (0.53) | PLA2G2CMCHR1PLA2G4BALDH1A1CYP3A4 | |
| SCHEMBL6814001 | 0.83 | PLA2G2C (0.53) | PLA2G2CMCHR1PLA2G4BALDH1A1CYP3A4 | |
| SCHEMBL25956397 | 0.83 | PLA2G2C (0.53) | PLA2G2CMCHR1PLA2G4BALDH1A1CYP3A4 | |
| SCHEMBL9575934 | 0.83 | PLA2G2C (0.53) | PLA2G2CMCHR1PLA2G4BALDH1A1CYP3A4 | |
| SCHEMBL9575937 | 0.83 | PLA2G2C (0.53) | PLA2G2CMCHR1PLA2G4BALDH1A1CYP3A4 | |
| SCHEMBL25967510 | 0.83 | PLA2G2C (0.53) | PLA2G2CMCHR1PLA2G4BALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230233593-A1 | ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS | VenatoRx Pharmaceuticals, Inc. | 2023-07-27 | — | — | US | disclosed |
| US-11638715-B2 | Orally-bioavailable nucleoside analogs | VenatoRx Pharmaceuticals, Inc. (US) | 2023-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11638715-B2 | Orally-bioavailable nucleoside analogs | SLC29A2, SLC29A1, PNP | PLA2G2C 3210/4885MCHR1 4167/4885PLA2G4B 2366/4885 |
| US-20230233593-A1 | ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS | SLC29A2, SLC29A1, PNP | PLA2G2C 3210/4885MCHR1 4167/4885PLA2G4B 2366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.